The national register of hepatitis C infections with a known date of acquisition

March 2005
Gut;Mar2005, Vol. 54 Issue 3, p442
Academic Journal
The article reports that in 1998, a national register of hepatitis C virus (HCV) infections with a known date of acquisition was established. The register was set up to help inform the natural history of HCV related disease in Great Britain and now contain anonymous data for one of the latest cohorts of individuals with known data HCV infections, with over 1120 registered patients. The majority of infections in the register are those that were acquired following transfusion of HCV infected blood that was issued before the introduction of routine screening of the blood supply for HCV, but other routes of acquisition are represented.


Related Articles

  • High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Sampietro, Maurizio; Badalamenti, Salvatore; Salvadori, Samantha; Corbetta, Noemi; Graziani, Giorgio; Como, Giovanna; Fiorelli, Gemino; Ponticelli, Claudio // Kidney International;Mar1995, Vol. 47 Issue 3, p911 

    Hepatitis C virus (HCV) is a major cause of hepatitis among patients treated with maintenance hemodialysis. Blood transfusion appears to be the primary risk factor, but nosocomial transmission of HCV in the dialytic environment has been hypothesized. We addressed this issue by analyzing the...

  • A shield against a monster: Hepatitis C in hemodialysis patients. Alavian, Seyed-Moayed // World Journal of Gastroenterology;2/14/2009, Vol. 15 Issue 6, p641 

    Hepatitis C virus (HCV) infection is highly prevalent among patients on hemodialysis (HD). The prevalence of HCV infection in HD patients varies markedly from country to country. Some factors are especially related to these high prevalence rates, such as blood transfusions and length of dialysis...

  • New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Medhi, Subhash; Goswami, Bhabadev; Das, Anup; Singh, Thongam; Husain, Syed; Sehgal, Ashok; Kar, Premashis // Archives of Virology;Nov2012, Vol. 157 Issue 11, p2083 

    Northeast India is known for the demographic heterogeneity of its tribal population, but there is no information about hepatitis C virus infection and associated risk factors. Anti-HCV was measured, HCV-RNA was detected based on the 5' UTR-core region, and genotyping was done by direct...

  • Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Knudsen, Freddy; Wantzin, Per; Rasmussen, Knud; Ladefoged, Søren D.; Løkkegaard, Niels; Rasmussen, Lars S.; Lassen, Anders; Krogsgaard, Kim // Kidney International;Jun1993, Vol. 43 Issue 6, p1353 

    Antibodies to hepatitis C virus (anti-HCV) were determined in an unselected group of 340 patients with chronic renal failure treated with maintenance dialysis. A second generation hepatitis C virus (HCV) enzyme-linked immunosorbent assay (ELISA) was used and confirmation made by a second...

  • Research highlights.  // Nature;6/16/2005, Vol. 435 Issue 7044, p858 

    This article focuses on recent findings. More than 170 million people worldwide are infected with the virus that causes hepatitis C, a major liver disease. Understanding the life cycle of the virus is essential for developing effective treatments. In independent papers, three teams now report...

  • Fibrosis progression in chronic hepatitis C virus infection. McCaughan, G. W.; George, J. // Gut;Mar2004, Vol. 53 Issue 3, p318 

    Chronic hepatitis C virus infection is typically characterised by slowly progressive hepatic fibrosis. However, it is recognised that some patients do not progress while others rapidly develop significant fibrosis. Here, we review studies that have assessed factors that could influence this rate...

  • The Prevalence of Hepatitis C in Patients with Porphyria Cutanea Tarda in Stockholm, Sweden. Linde, Ylva; Harper, Pauline; Floderus, Ylva; Ros, Anne-Marie // Acta Dermato-Venereologica;Mar2005, Vol. 85 Issue 2, p164 

    In many countries hepatitis C virus infection has been considered a major factor triggering overt porphyria cutanea tarda. The prevalence of hepatitis C virus infection was retrospectively studied in 87 patients who during a period of 11 years were diagnosed with porphyria cutanea tarda in...

  • Exposure of Hepatitis C Virus-Negative Recipients to ...2 Infected Blood Donors. Laskus, Tomasz; Wilkinson, Jeffrey; Rakela, Jorge; Wang, Lian-Fu; Radkowski, Marek; Nowicki, Marek // Journal of Infectious Diseases;2/15/2001, Vol. 183 Issue 4, p666 

    Features a study which analyzed cases of hepatitis C virus (HCV)-naive transfusion recipients who developed hepatitis after receiving blood from HCV-infected donor. Subjects; Reverse transcriptase polymerase chain reaction detection of HCV RNA; Results; Discussion.

  • Eligibility for Treatment of Hepatitis C Virus Infection among Young Injection Drug Users in 3 Us Cities. Hagan, Holly; Latka, Mary H.; Campbell, Jennifer V.; Golub, Elizabeth T.; Garfein, Richard S.; Thomas, David A.; Kapadia, Farzana; Strathdee, Steffanie A. // Clinical Infectious Diseases;3/1/2006, Vol. 42 Issue 5, p669 

    Among 404 injection drug users aged 18–35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics